171 related articles for article (PubMed ID: 15078651)
1. Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Asch DA
Arch Intern Med; 2004 Apr; 164(7):801-3. PubMed ID: 15078651
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and Ethics of Incentives for Research Participation: 2 Randomized Clinical Trials.
Halpern SD; Chowdhury M; Bayes B; Cooney E; Hitsman BL; Schnoll RA; Lubitz SF; Reyes C; Patel MS; Greysen SR; Mercede A; Reale C; Barg FK; Volpp KG; Karlawish J; Stephens-Shields AJ
JAMA Intern Med; 2021 Nov; 181(11):1479-1488. PubMed ID: 34542553
[TBL] [Abstract][Full Text] [Related]
3. Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiency.
Halpern SD; Karlawish JH; Casarett D; Berlin JA; Townsend RR; Asch DA
Am Heart J; 2003 Dec; 146(6):985-92. PubMed ID: 14660989
[TBL] [Abstract][Full Text] [Related]
4. Regulated payments for living kidney donation: an empirical assessment of the ethical concerns.
Halpern SD; Raz A; Kohn R; Rey M; Asch DA; Reese P
Ann Intern Med; 2010 Mar; 152(6):358-65. PubMed ID: 20231566
[TBL] [Abstract][Full Text] [Related]
5. Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.
Krutsinger DC; McMahon J; Stephens-Shields AJ; Bayes B; Brooks S; Hitsman BL; Lubitz SF; Reyes C; Schnoll RA; Ryan Greysen S; Mercede A; Patel MS; Reale C; Barg F; Karlawish J; Polsky D; Volpp KG; Halpern SD
Contemp Clin Trials; 2019 Jan; 76():1-8. PubMed ID: 30414865
[TBL] [Abstract][Full Text] [Related]
6. Informative inducement: study payment as a signal of risk.
Cryder CE; John London A; Volpp KG; Loewenstein G
Soc Sci Med; 2010 Feb; 70(3):455-464. PubMed ID: 19926187
[TBL] [Abstract][Full Text] [Related]
7. Economic vulnerability and payment for research participation.
Gelinas L; White SA; Bierer BE
Clin Trials; 2020 Jun; 17(3):264-272. PubMed ID: 32063065
[TBL] [Abstract][Full Text] [Related]
8. The influence of risk and monetary payment on the research participation decision making process.
Bentley JP; Thacker PG
J Med Ethics; 2004 Jun; 30(3):293-8. PubMed ID: 15173366
[TBL] [Abstract][Full Text] [Related]
9. Participants' Perspectives on Payment for Research Participation: A Qualitative Study.
Largent EA; Eriksen W; Barg FK; Greysen SR; Halpern SD
Ethics Hum Res; 2022 Nov; 44(6):14-22. PubMed ID: 36316972
[TBL] [Abstract][Full Text] [Related]
10. Our flawed approach to undue inducement in medical research.
Lee E
Bioethics; 2019 Jan; 33(1):13-18. PubMed ID: 30014475
[TBL] [Abstract][Full Text] [Related]
11. Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information.
Devine EG; Knapp CM; Sarid-Segal O; O'Keefe SM; Wardell C; Baskett M; Pecchia A; Ferrell K; Ciraulo DA
Contemp Clin Trials; 2015 Mar; 41():55-61. PubMed ID: 25530307
[TBL] [Abstract][Full Text] [Related]
12. Paying Research Participants: Regulatory Uncertainty, Conceptual Confusion, and a Path Forward.
Largent EA; Fernandez Lynch H
Yale J Health Policy Law Ethics; 2017; 17(1):61-141. PubMed ID: 29249912
[TBL] [Abstract][Full Text] [Related]
13. Exploitation in payments to research subjects.
Phillips T
Bioethics; 2011 May; 25(4):209-19. PubMed ID: 19438444
[TBL] [Abstract][Full Text] [Related]
14. Undue inducement: the only objection to payment?
VanderWalde A
Am J Bioeth; 2005; 5(5):25-7. PubMed ID: 16179303
[No Abstract] [Full Text] [Related]
15. Children in Social Research: Do Higher Payments Encourage Participation in Riskier Studies?
Taplin S; Chalmers J; Hoban B; McArthur M; Moore T; Graham A
J Empir Res Hum Res Ethics; 2019 Apr; 14(2):126-140. PubMed ID: 30735083
[TBL] [Abstract][Full Text] [Related]
16. Undue fear of inducements in research in developing countries.
Arnason G; Van Niekerk A
Camb Q Healthc Ethics; 2009 Apr; 18(2):122-9. PubMed ID: 19250565
[No Abstract] [Full Text] [Related]
17. Paying hypertension research subjects.
Casarett D; Karlawish J; Asch DA
J Gen Intern Med; 2002 Aug; 17(8):650-2. PubMed ID: 12213148
[TBL] [Abstract][Full Text] [Related]
18. When Does the Amount We Pay Research Participants Become "Undue Influence"?
Williams EP; Walter JK
AMA J Ethics; 2015 Dec; 17(12):1116-21. PubMed ID: 26698584
[No Abstract] [Full Text] [Related]
19. Payment to healthy volunteers in clinical research: the research subject's perspective.
Czarny MJ; Kass NE; Flexner C; Carson KA; Myers RK; Fuchs EJ
Clin Pharmacol Ther; 2010 Mar; 87(3):286-93. PubMed ID: 20090675
[TBL] [Abstract][Full Text] [Related]
20. Misconceptions about coercion and undue influence: reflections on the views of IRB members.
Largent E; Grady C; Miller FG; Wertheimer A
Bioethics; 2013 Nov; 27(9):500-7. PubMed ID: 22493972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
